Crossmark

Which nasopharyngeal cancer patients need adaptive radiotherapy?

Crossref DOI link: https://doi.org/10.1186/s12885-018-5159-y

Published Online: 2018-12-10

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Yu-Chang

Tsai, Kuo-Wang

Lee, Ching-Chih

Peng, Nan-Jing

Chien, Ju-Chun

Tseng, Hsin-Hui

Chen, Po-Chun

Lin, Jin-Ching

Liu, Wen-Shan http://orcid.org/0000-0001-9721-6921
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 27 March 2018

Accepted: 29 November 2018

First Online: 10 December 2018

Ethics approval and consent to participate

: The protocol for this study was approved by the Institutional Review Board of Kaohsiung Veterans General Hospital (Protocol number 160310–2). This research is retrospective dosimetric review and comparison with a phantom plan. Informed consent for individual patients has been waived by our IRB, named Institutional Review Board of Kaohsiung Veterans General Hospital.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.